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nature publishing group addition, these agents are almost certainly involved in the pathogenesis of ulcerative colitis, alcoholic liver disease, nonalcoholic steatohepatitis, and metabolic syndrome. 4 -7 Crohn ' s disease seems to be an inappropriately aggressive TH1 and / or TH17 immune response to a subset of commensal intestinal bacteria in genetically susceptible hosts, which is initiated and reactivated by transient infectious or environmental triggers. 3, 4, 8, 9 These triggers break the mucosal barrier and activate an initial nonspecifi c immune response, which becomes chronic because of the constant drive of commensal microbial antigens in hosts that have genetic defects in mucosal barrier function or repair, bacterial killing by innate immune cells or Paneth cells, or immunoregulation.
The profile of both fecal and mucosally associated bacteria exhibit changes described as " dysbiosis " in a subset ( ~ 1 / 3) of inflammatory bowel disease (IBD) patients with active disease and in rodents with experimental colitis that are characterized by decreased bacterial diversity and an altered ratio of beneficial and aggressive bacterial species. 1, 10 These alterations include decreased concentrations of the Lachnospiraceae subset of Clostridiales, and variable changes in Bacteroidetes, with a concomitant increase in Proteobacteria and Actinobacteria (except Bifi dobacterides). Bacterial species that are consistently increased in human IBD and experimental colitis include Escherichia coli , specifi cally the B2 and D phylotypic groups and adherent / invasive strains associated with ileal Crohn ' s disease. 11 -13 In addition, experimental TH1 / TH17 activation and colitis in monoassociated interleukin-10-defi cient mice alter gene expression in a commensal adherent / invasive E. coli strain in preliminary experiments, with upregulation of bacterial stress-response genes. 14 In recent studies, Rumino coccus gnavus , Klebsiella pneumoniae , and Proteus mirabilis have been implicated in Crohn ' s disease and experimental colitis. 15, 16 Conversely, Faecalibacterium prausnitzii , a major representative of the butyrate-producing Clostridium leptum group of the Lachnospiraceae family, is decreased in ileal and colonic Crohn ' s disease and has been reported to provide protection in experimental colitis and to predict relapse of postoperative ileal Crohn ' s disease. 17, 18 Commensal bacteria have an essential role in driving immune-mediated experimental infl ammation in the distal intestine. 4, 6, 18 Germ-free genetically susceptible mice and rats exhibit no evidence of chronic colitis under germ-free (sterile) conditions and CD4 + T cells produce interferon-and interleukin-17 in response to cecal bacterial lysates and bacterial antigens in specifi c pathogenfree genetically engineered rodents and aft er selective colonization with some, but not all, bacterial species in gnotobiotic rodents. 19, 20 It is diffi cult to predict the pathophysiological effects in vivo due to host-specifi c eff ects, as segmented fi lamentous bacterium, a noncultivatable commensal that induces TH17 responses in wild-type noninfl amed mice 21 did not induce colitis when monoassociated in the SCID (severe combined immunodefi ciency) mouse CD45RBhigh transfer model, 22 and Bifi dobacterium animalis , normally considered to be a protective probiotic strain, can cause colitis in monoassociated interleukin-10-defi cient mice. 23, 24 In contrast, other commensal species and their defi ned components and secreted products have predominantly protective properties. 18, 25 Th ese studies demonstrate both host and bacterial species specifi city, as only a relatively small subset of commensal bacterial species will induce experimental colitis, 19, 20 diff erent hosts respond selectively to the same bacterial species, 26 two diff erent commensal bacterial species can induce different phenotypes of infl ammation in the same host 20 and have additive eff ects, 27 and commensal specifi c pathogen-free bacterial species that induce colitis in susceptible hosts do not cause infl ammation in wild-type hosts. 19, 20 Even diff erent E. coli strains have variable abilities to induce experimental, immune-mediated colitis, as adherent-invasive nontoxigenic E. coli strains, including a human ileal Crohn ' s disease isolate, induce chronic colitis, but a nonadherent strain does not. 28 Th ese observations lay the foundation for the hypothesis that a subset of nonpathogenic commensal bacteria provide the constant antigenic drive of IBD in genetically susceptible hosts, whereas other endogenous species primarily induce protective regulatory immune responses. Th e relative balance of these aggressive vs. benefi cial organisms determine infl ammation vs. homeostasis and potentially can be manipulated for therapeutic benefi t ( Table 1 ) .
Th e following key questions to better understand microbial -host interactions remain unresolved. Selected illustrations by currently available data are provided.
IS DYSBIOSIS A CAUSE OR A CONSEQUENCE OF INTESTINAL

INFLAMMATION?
Th e primary vs. secondary nature of the characteristic pattern of decreased Clostridial groups IV (including F. prausnitzii ) Th is question is integral to the duration of microbial-based therapies, including fecal transplant. Although an indivi dual ' s fecal microbiota changes daily with dietary and environmental shift s, there is a remarkable long-term stability of the intestinal bacterial population. 36 Probiotic administration only transiently alters fecal bacterial composition due to a lack of long-term colonization, with reversion to baseline within 2 weeks of ceasing therapy. 37 However, despite earlier evidence to the contrary, recent data indicate long-term changes in microbial composition and diversity aft er antibiotic therapy, particularly if administered cyclically. 38 -40 Th ese observations, along with transfer of colitis 16, 29 and metabolic syndrome 5 by fecal inoculation and activation of ileal interleukin-17 responses by colonization with a specifi c bacterial species (segmented fi lamentous bacterium), 21 suggest that immunological eff ects of commensal bacterial transfer may be sustained over at least several months. The prospect of permanently changing the intestinal microbiota in older children and adults remains speculative at present.
WHAT ARE THE RELATIVE INFLUENCES OF GENETICS VS. ENVIRONMENTAL FACTORS IN SHAPING THE INTESTINAL MICROBIOME?
Multiple factors contribute to the development of the intestinal microbiota, including maternal transmission, early life exposures, diet, and genetics. 1, 41 However, the relative roles of environmental vs. genetic infl uences are not yet well understood. In a seminal metagenomic study, Turnbaugh et al. 42 demonstrated that the degree of similarity between monozygotic and dizygotic twin pairs was not significantly diff erent, although monozygotic twins had a trend toward greater similarity, and that bacterial communities were more similar within family members than between diff erent families, suggesting a primary role for early shared exposure rather than genetic direction of microbial composition. In contrast, Frank et al. 43 reported that the NOD 2 (nucleotidebinding oligomerization domain containing 2) composite genotype, ATG 16L1 polymorphisms, and ileal disease location were associated with mucosal dysbiosis in patients with Crohn ' s disease. Similarly, NOD 2 defi ciency in mice resulted in decreased F. prausnitzii ileal mucosal concentrations. 44 Similarly, monoassociation of 23 inbred mouse strains with the defi ned altered Schaedler fl ora indicated important genetic eff ects, 45 although the lack of diff erences in the fecal microbiota in two diff erent mouse strains implanted into a foster mother demonstrated lasting effects of maternal microbiota transmission. 46 Th ese and other studies have revealed that both genotype and environmental infl uences, mostly diet and early microbial exposure, combine to shape enteric microbiota composition, which remains quite stable once developed.
DOES INITIAL BACTERIAL COLONIZA-TION AND EARLY ENVIRONMENTAL EXPOSURES DETERMINE LIFE-LONG BACTERIAL COMPOSITION?
Transition from the sterile amniotic sac to the external environment is accom panied by progressive transition to increasingly complex microbiota over time. 47, 48 Initial colonization depends on mode of delivery, with vaginally delivered infants acquiring microbial communities resembling their mother ' s vaginal microbiota dominated by Lactobacillus , Prevotella , or Sneathia spp., whereas infants delivered by Cesarian section acquired skin organisms, including Staphylococcus , Corynebacterium , and Propionibacterium spp. 49 Initial communities are aerobic, transitioning gradually to the anaerobic complex microbiota. Maternal and paternal infl uences are evident in twin studies, with shared environment more important than genetic infl uences. 42 Dominant maternal infl uences on transmitted bacterial communities are confi rmed by mouse studies. 46 Dietary regulation is important, with domination of the preweaning microbiota by the lactose-responsive Bifi dobacterium and Lactobacillus spp. and rapid diversifi cation of bacterial communities aft er weaning. 50 Somewhat surprisingly, cultivatable bacterial communities do not seem to be influenced heavily by breast vs. bottle feeding, with the exception of Lactobacillus rhamnosus . 47, 48 As atopic disorders appear to be linked to early ( < 6 months of age) microbiota composition, 51 multiple investigators have explored early probiotic intervention in infants or even mothers with atopic conditions in the third trimester of pregnancy, usually with little success. 52 Although most authors state that the human microbiota is stabilized by 12 months of age, transplantation of the human microbiota to germ-free (sterile) adult mice shows that the absence of competing organisms can obviate age eff ects. 53 Th ese studies suggest that the potential of targeting infants at high risk for developing immunological diseases for constitution with the " healthy " microbiota to prevent the onset of disease has not yet been achieved. Th is potentially important area of investigation needs to be further explored in rodent models, in which consequences of experimentation are acceptable and mechanistic studies can be performed. Early intervention in infancy or during pregnancy could be a very physiological and nontoxic approach to altering life-long risk of COMMENTARIES nature publishing group familial infl ammatory / allergic conditions, given the apparent importance of early infant colonization on adult microbial communities.
INFECTIOUS AGENTS: TRIGGERS OR CHRONIC STIMULI?
Although the essential role for the commensal microbiota as antigenic stimuli of eff ector immune responses in chronic intestinal inflammation is broadly accepted, the importance of traditional and opportunistic pathogens in IBD remains quite controversial. An etiological role for MAP ( Mycobacterium avium subspecies paratuberculosis ) in Crohn ' s disease is not widely supported, but the intriguing possibility that an obligate intracellular opportunistic pathogen such as MAP or adherent / invasive E. coli selectively persists within macrophages of individuals with genetic defects in intracellular microbial clearance, such as NOD 2, ATG 16L1, and IGRM, must be considered. 4 Chronic infections can cause persistent enterocolitis in normal hosts, with potentiation of injury in susceptible hosts, as illustrated by enterotoxigenic Bacteroides fragilis . 54 Transient infection by traditional enteric pathogens can trigger chronic, immune-mediated experimental intestinal infl ammation 6 and is linked to human IBD in epidemiological studies. 55 Potential mechanisms include breaking the mucosal barrier and / or activating pathogenic immune responses that are subsequently perpetuated by commensal enteric antigens in genetically susceptible hosts who are unable to repair epithelial breaches or downregulate the infl ammatory response. An alternative mechanism is priming of adaptive immune responses to commensal bacteria, as documented for Helicobacter bilis 56 and cytomegalovirus 57 infection. Cadwell et al. 9 recently provided powerful proof of the concept that infectious triggers can interact with host genetic susceptibility to induce disease. Noravirus infection induced a characteristic abnormality in Paneth cell granules in ATG 16L1 mutant mice, similar to those in Crohn ' s disease patients with ATG 16L1 polymorphisms, and potentiated acute toxin-induced colitis, which was driven in part by commensal bacteria. Neither the genetic defect nor viral infection alone was suffi cient to induce the Paneth cell phenotype or potentiate toxin-induced colitis; only the interaction of the viral trigger with genetic defect enhanced colitis.
CAN ENDOGENOUS PROTECTIVE COMMENSAL BACTERIAL SPECIES MORE EFFECTIVELY TREAT AND PREVENT
INFLAMMATORY DISEASES THAN WILL TRADITIONAL PROBIOTIC SPECIES?
Traditional probiotic species are an attractive potential treatment of intestinal infl ammation, but results to date have not lived up to their promise, despite well-documented immunosuppressive eff ects. 58, 59 In addition to their immunoregulatory activity, at least one probiotic species strongly infl uences gene expression and metabolism of commensal bacteria. 60 An important limitation of the currently available probiotic preparations, which are traditionally derived from fermented foods rather than commensal enteric bacterial species, is their inability to colonize the distal intestine and persist aft er administration ceases. 4, 59 A potential solution is to use commensal protective bacterial species, such as F. prausnitzii , B. fragilis , host-derived Lactobacillus , Bifidobacterium , and E. coli strains, which exhibit protective activities in experimental murine studies. Th is strategy is particularly appealing as a means to correct specifi c defi ciencies in protective commensal bacterial concentrations in an individual, such as selective replacement of low numbers of mucosally adherent F. prausnitzii , which is a risk factor for postoperative recurrence of Crohn ' s disease. 18 
WHAT IS THE ROLE OF DIET IN SHAPING AND MANIPULATING ENTERIC BACTERIAL COMPOSITION, FUNCTION, AND METABOLISM?
An extremely important yet vastly underexplored fi eld is the eff ect of diet on the gut microbiome. Nascent studies clearly demonstrate the ability of various human diets to alter enteric bacterial composition, gene expression, and metabolic activity in reconstituted gnotobiotic mice. 61, 62 Dietary manipulation, which includes the use of prebiotic substances that foster the growth and metabolic activity of endogenous butyrate-producing bacterial species, provides great promise for an extremely physiological and cost-eff ective approach to modify the intestinal microbiome in order to treat and prevent infl ammatory diseases in high-risk individuals. 4, 63, 64 WHAT ARE THE EFFECTS OF MICROBIAL
METABOLITES ON EFFECTOR AND REGULATORY MUCOSAL IMMUNE FUNCTION AND INFLAMMATION?
Intestinal bacteria are metabolically active and greatly contribute to the gut metabolome. Th ese organisms use either dietary or host-derived carbohydrate substrates, the availability of which can almost immediately alter bacterial gene expression to upregulate or downregulate various bacterial genes and metabolic pathways. 62 Nonabsorbed dietary carbohydrates (fi ber, prebiotics) are substrates used by subsets of enteric anaerobic bacteria to produce benefi cial short-chain fatty acids, most notably butyrate, which is the primary energy substrate for distal colonocytes and suppresses immune activation. Recent studies indicate multiple mechanisms and immunosuppression by butyrate, including inhibition of histone deacetylases and induction of apoptosis. 65, 66 In contrast, bacterial production of toxic metabolites, such as hydrogen sulfi de, nitrous oxide, and reactive oxygen metabolites, can injure epithelial cells and potentially induce chronic intestinal infl ammation. 67 
HOW DO COMMENSAL FUNGI AND VIRUSES AFFECT INTESTINAL IMMUNE FUNCTION, INFLAMMATORY PROCESSES, AND BACTERIAL
COMPOSITION AND FUNCTION?
Another virtually unexplored frontier of the gut microbiota is the lush fungal and viral elements that can directly aff ect intestinal epithelial cells and mucosal immune responses and can influence intestinal bacterial populations and function. Bacteriophages off er an opportunity to modulate specifi c bacterial populations because of their selective tropism. Recent molecular surveys identify abundant commensal viruses mainly targeting commensal bacteria. 68 As mentioned above, noravirus can induce aberrant Paneth cell nature publishing group COMMENTARIES granule morphology and potentiate acute experimental colitis. 9 
CONCLUSIONS AND FUTURE
DIRECTIONS
Commensal enteric bacteria provide an essential role in the pathogenesis of Crohn ' s disease and probably other chronic, immune-mediated infl ammatory conditions in the intestine and liver, and also provide obligate stimuli for the normal development and diff eren tiation of mucosal immune responses. IBD requires interactions between genetic susceptibility, environmental triggers, enteric microbiota, and eff ector and regulatory immune responses, as outlined in Figure 1 . Although recent breakthroughs in molecular techniques have led to a rapid evolution in our understanding of the enteric bacterial composition, many questions remain regarding their function and their complex mutualistic interplay with the host. Answering the questions posed in this commentary will begin to address some of the most obvious gaps in our knowledge of host -microbial interactions that determine chronic immune-mediated infl ammation vs. mucosal homeostasis and peaceful coexistence with our complex gut microbiota. Th is knowledge will lay the foundation for novel therapeutic interventions that extend beyond our current reliance on probiotics arising from fermented dairy products. 
